A Reduced-Toxicity Regimen Is Associated with Durable Engraftment and Clinical Cure of Nonmalignant Genetic Diseases among Children Undergoing Blood and Marrow Transplantation with an HLA-Matched Related Donor

Kris Michael Mahadeo, Kenneth I. Weinberg, Hisham Abdel-Azim, David B. Miklos, Renna Killen, Donald Kohn, Gay M. Crooks, Ami J. Shah, Sandhya Kharbanda, Rajni Agarwal, Neena Kapoor

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)440-444
Number of pages5
JournalBiology of Blood and Marrow Transplantation
Volume21
Issue number3
DOIs
StatePublished - Mar 1 2015
Externally publishedYes

ASJC Scopus Subject Areas

  • Hematology
  • Transplantation

Keywords

  • Alemtuzumab
  • Nonmalignant diseases
  • Pediatrics
  • Reduced toxicity

Cite this